Serina Therapeutics CEO Discusses Parkinson's Drug Progress in Webinar
1 report, 1 independent
Updated Sep 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tribe Public LLC hosted a webinar on September 1, 2026, featuring Serina Therapeutics' CEO, Steven Ledger. The presentation, titled "A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress," was streamed using Zoom. Serina Therapeutics is a clinical-stage biotechnology company developing treatments for neurological diseases.
From manilatimes.net
Why it matters
The event provided an update on SER-252, Serina Therapeutics' lead program for advanced Parkinson’s disease, which utilizes the company's proprietary POZ Platform™ technology. This presentation highlights the company's pipeline and clinical progress in the neurological drug market.
From manilatimes.net
Who's involved
- Mission DistrictFacilitated the corporate sponsored global event
- SECClinical-stage biotechnology company developing drug candidates for neurological diseases
- ZoomProvided the streaming platform for the CEO presentation
Keep exploring
The entities involved
-
Zoom
stream
-
San Francisco
consolidated city and county in California, United States